Testing effectiveness (Phase 2)Ended earlyNCT02203604
What this trial is testing
High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
CINJRegulatory 9